BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cava C, Bertoli G, Castiglioni I. A protein interaction map identifies existing drugs targeting SARS-CoV-2. BMC Pharmacol Toxicol 2020;21:65. [PMID: 32883368 DOI: 10.1186/s40360-020-00444-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Jha P, Singh P, Arora S, Sultan A, Nayek A, Ponnusamy K, Syed MA, Dohare R, Chopra M. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients. J Cell Biochem 2022. [PMID: 35037717 DOI: 10.1002/jcb.30213] [Reference Citation Analysis]
2 Sabetian S, Castiglioni I, Jahromi BN, Mousavi P, Cava C. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection. Cells 2021;10:1480. [PMID: 34204705 DOI: 10.3390/cells10061480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen T, Philip M, Lê Cao KA, Tyagi S. A multi-modal data harmonisation approach for discovery of COVID-19 drug targets. Brief Bioinform 2021:bbab185. [PMID: 34036326 DOI: 10.1093/bib/bbab185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee Y, Ng M, Daniel K, Wayne E. Rapid growth in the COVID-19 era. MRS Bull 2021;:1-7. [PMID: 34608355 DOI: 10.1557/s43577-021-00185-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ackerman EE, Shoemaker JE. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning. Viruses 2020;12:E1087. [PMID: 32993136 DOI: 10.3390/v12101087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, Kosti I, Leon KE, Bunis DG, Li C, Kumar GR, White KM, García-Sastre A, Ott M, Sirota M. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Sci Rep 2021;11:12310. [PMID: 34112877 DOI: 10.1038/s41598-021-91625-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cava C, Sabetian S, Castiglioni I. Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data. Entropy (Basel) 2021;23:225. [PMID: 33670375 DOI: 10.3390/e23020225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huang YJ, Zhao H, Huang X, Deng YQ, Li XF, Ye Q, Li RT, Xu YP, Cao TS, Qin CF. Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants. Cell Discov 2021;7:116. [PMID: 34845185 DOI: 10.1038/s41421-021-00354-2] [Reference Citation Analysis]
9 Elekhnawy E, Kamar AA, Sonbol F. Present and future treatment strategies for coronavirus disease 2019. Futur J Pharm Sci 2021;7:84. [PMID: 33850936 DOI: 10.1186/s43094-021-00238-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Maiese K. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes. Curr Neurovasc Res 2020;17:765-83. [PMID: 33183203 DOI: 10.2174/1567202617999201111195232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Quarato V, D’antona S, Battista P, Zupo R, Sardone R, Castiglioni I, Porro D, Frasca M, Cava C. Transcriptional Profiling of Hippocampus Identifies Network Alterations in Alzheimer’s Disease. Applied Sciences 2022;12:5035. [DOI: 10.3390/app12105035] [Reference Citation Analysis]
13 Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, Kosti I, Leon KE, Bunis DG, Li C, Kumar GR, White KM, García-Sastre A, Ott M, Sirota M. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Res Sq 2021:rs. [PMID: 33821262 DOI: 10.21203/rs.3.rs-333578/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cava C, Bertoli G, Castiglioni I. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation. Future Virol 2021. [PMID: 34306168 DOI: 10.2217/fvl-2020-0392] [Reference Citation Analysis]
15 Dong W, Yang X, Li J, Zhang Z, Liu L, Zhao Z, Kang L. Smaller reaction volume of triplex taqman real-time reverse transcription-PCR assays for diagnosing coronavirus disease 2019. J Clin Lab Anal 2021;:e24137. [PMID: 34859916 DOI: 10.1002/jcla.24137] [Reference Citation Analysis]